BiotechTube
Home/Immusoft/Rob Hayes, Ph.D.
RH

Rob Hayes, Ph.D.

Chief Scientific Officer

Immusoft

Therapeutic Areas

Rare Genetic DiseasesLysosomal Storage Disorders

Immusoft Pipeline

DrugIndicationPhase
ISP-001Mucopolysaccharidosis type I (MPS I)Preclinical

Leadership Team at Immusoft

SA
Sean Ainsworth
Chief Executive Officer & Chairman
RS
Robert Sikorski, M.D., Ph.D.
Chief Medical Officer
View full Immusoft profile